NCT04763707View on ClinicalTrials.gov

Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

November 1, 2022

Conditions
Hepatocellular Carcinoma
Trial Locations (1)

82524

Faculty of Medicine, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT04763707 - Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis | Biotech Hunter | Biotech Hunter